264 related articles for article (PubMed ID: 18546293)
1. Global analysis of metastasis-associated gene expression in primary cultures from clinical specimens of clear-cell renal-cell carcinoma.
Tan X; Zhai Y; Chang W; Hou J; He S; Lin L; Yu Y; Xu D; Xiao J; Ma L; Wang G; Cao T; Cao G
Int J Cancer; 2008 Sep; 123(5):1080-8. PubMed ID: 18546293
[TBL] [Abstract][Full Text] [Related]
2. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
Kosari F; Parker AS; Kube DM; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Vasmatzis G
Clin Cancer Res; 2005 Jul; 11(14):5128-39. PubMed ID: 16033827
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
[TBL] [Abstract][Full Text] [Related]
4. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
[TBL] [Abstract][Full Text] [Related]
5. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
[TBL] [Abstract][Full Text] [Related]
6. CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases.
Wuttig D; Zastrow S; Füssel S; Toma MI; Meinhardt M; Kalman K; Junker K; Sanjmyatav J; Boll K; Hackermüller J; Rolle A; Grimm MO; Wirth MP
Int J Cancer; 2012 Sep; 131(5):E693-704. PubMed ID: 22213152
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X
J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019
[TBL] [Abstract][Full Text] [Related]
8. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
[TBL] [Abstract][Full Text] [Related]
9. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma.
Ni D; Ma X; Li HZ; Gao Y; Li XT; Zhang Y; Ai Q; Zhang P; Song EL; Huang QB; Fan Y; Zhang X
Clin Cancer Res; 2014 Apr; 20(7):1779-90. PubMed ID: 24486593
[TBL] [Abstract][Full Text] [Related]
11. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor.
Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D
Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
Du P; Ye L; Yang Y; Jiang WG
Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of miR-497 is associated with poor prognosis in renal cancer.
Zhao X; Zhao Z; Xu W; Hou J; Du X
Int J Clin Exp Pathol; 2015; 8(1):758-64. PubMed ID: 25755771
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic significance of a comprehensive epithelial-mesenchymal transition gene set in renal cell carcinoma.
Chen D; Gassenmaier M; Maruschke M; Riesenberg R; Pohla H; Stief CG; Zimmermann W; Buchner A
J Urol; 2014 Feb; 191(2):479-86. PubMed ID: 24012533
[TBL] [Abstract][Full Text] [Related]
15. miR-629 Targets TRIM33 to Promote TGFβ/Smad Signaling and Metastatic Phenotypes in ccRCC.
Jingushi K; Ueda Y; Kitae K; Hase H; Egawa H; Ohshio I; Kawakami R; Kashiwagi Y; Tsukada Y; Kobayashi T; Nakata W; Fujita K; Uemura M; Nonomura N; Tsujikawa K
Mol Cancer Res; 2015 Mar; 13(3):565-74. PubMed ID: 25381221
[TBL] [Abstract][Full Text] [Related]
16. Expression of miRNA-21 and miRNA-221 in clear cell renal cell carcinoma (ccRCC) and their possible role in the development of ccRCC.
Szabó Z; Szegedi K; Gombos K; Mahua C; Flaskó T; Harda K; Halmos G
Urol Oncol; 2016 Dec; 34(12):533.e21-533.e27. PubMed ID: 27427222
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of long non-coding RNA ENSG00000241684 is associated with poor prognosis in advanced clear cell renal cell carcinoma.
Su H; Wang H; Shi G; Zhang H; Sun F; Ye D
Eur J Surg Oncol; 2018 Jun; 44(6):840-846. PubMed ID: 29433989
[TBL] [Abstract][Full Text] [Related]
18. High TXNDC5 expression predicts poor prognosis in renal cell carcinoma.
Mo R; Peng J; Xiao J; Ma J; Li W; Wang J; Ruan Y; Ma S; Hong Y; Wang C; Gao K; Fan J
Tumour Biol; 2016 Jul; 37(7):9797-806. PubMed ID: 26810069
[TBL] [Abstract][Full Text] [Related]
19. Gene signatures of progression and metastasis in renal cell cancer.
Jones J; Otu H; Spentzos D; Kolia S; Inan M; Beecken WD; Fellbaum C; Gu X; Joseph M; Pantuck AJ; Jonas D; Libermann TA
Clin Cancer Res; 2005 Aug; 11(16):5730-9. PubMed ID: 16115910
[TBL] [Abstract][Full Text] [Related]
20. Biomarker identification in clear cell renal cell carcinoma based on miRNA-seq and digital gene expression-seq data.
Guan L; Tan J; Li H; Jin X
Gene; 2018 Mar; 647():205-212. PubMed ID: 29253611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]